LEADERSHIP TO MOVE THE FIELD FORWARD
Our management team and current advisors have experience and expertise in advancing product candidates through clinical development and in implementing comprehensive global commercialization strategies in combination with established pharmaceutical partners and regional distributors. We bring experience in global women’s healthcare, fundraising, clinical and regulatory strategy and implementation, partnering and commercial product launches. Our expertise covers devices, therapeutics and diagnostics.
Sabrina Martucci Johnson
President and Chief Executive Officer
Ms. Johnson founded Daré Bioscience Operations, Inc. in 2015 and has served as President, CEO and a member of the Board of Directors since its inception and following its business combination with Cerulean Pharma Inc. on July 19, 2017, when the Company was renamed Daré Bioscience, Inc. Ms. Johnson is a life sciences executive committed to advancing improvements in women’s healthcare. Previously, Ms. Johnson served as President of WomanCare Global Trading, a specialty pharmaceutical company in female reproductive healthcare with commercial product distribution in over 100 countries, from October of 2014 to May of 2015, and Chief Financial Officer and Chief Operating Officer from July 2013 to October 2014. Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the United Kingdom-based non-profit division, from November 2012 to July 2013. From 2002 until its sale in 2010, Ms. Johnson served as Chief Financial Officer of Cypress Bioscience, Inc., a publicly-traded pharmaceutical company, and in addition served as its Chief Operating Officer from 2008 until its sale in 2010. Ms. Johnson began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on their recombinant factor VIII program, and later held marketing and sales positions with Advanced Tissue Sciences and Clonetics Corporation.
Ms. Johnson currently serves on the boards of Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer; the YWCA of San Diego County as Past President, PPPSW, Athena San Diego as Vice Chair, and the Clearity Foundation. Additionally. Ms. Johnson serves on the Board of Advisors of Tulane University School of Science & Engineering, Chair of University of California San Diego (UCSD) Librarian’s Advisory Board, and on the Audit Committee of Project Concern International. Ms. Johnson is also Immediate Past Co-President of Women Give San Diego, which funds non-profit organizations serving women and girls in San Diego.
Ms. Johnson has a Masters of International Management degree with honors from the American Graduate School of International Management (Thunderbird), a MSc. in Biochemical Engineering from the University of London, University College London and a BSc. in Biomedical Engineering from Tulane University, where she graduated magna cum laude. The Board of Directors believes that Ms. Johnson is qualified to serve as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors due to her leadership experience in life sciences, women’s reproductive healthcare, development and commercial distribution of healthcare products, capital raises, and her experience as an officer in life sciences and women’s reproductive healthcare non-profit and for-profit companies, including publicly traded companies.
Ms. Walters-Hoffert co-founded Daré Bioscience Operations, Inc. in 2015 and served as the company’s Chief Business Officer. Following the company’s business combination with Cerulean Pharma Inc. on July 19, 2017, she became the Chief Financial Officer of the renamed company, Daré Bioscience, Inc. During the 25 years prior to joining the team, Ms. Walters-Hoffert was an investment banker focused primarily on raising equity capital for, and providing advisory services to, small-cap public companies. From 2003 to 2015, Ms. Walters-Hoffert worked for Roth Capital Partners, an investment banking firm focused on providing investment banking services to such companies, most recently serving as Managing Director in the Investment Banking Division, overseeing the firm’s San Diego office and its activities with respect to medical device, diagnostic and specialty pharma companies. At Roth Capital Partners, Ms. Walters-Hoffert trained and managed transaction deal teams and was responsible for the oversight of all aspects of transactions, including due diligence, internal communications with sales forces and external communications with institutional investors, among others. Ms. Walters-Hoffert has held various positions in the corporate finance and investment banking divisions of Citicorp Securities in San José, Costa Rica and Oppenheimer & Co, Inc. in New York City, New York.
Ms. Walters-Hoffert has served as a member of the Board of Directors of the San Diego Venture Group, as Past Chair of the UCSD Librarian’s Advisory Board and as Immediate Past Chair of the Board of Planned Parenthood of the Pacific Southwest. Ms. Walters-Hoffert graduated from Duke University with a BS in Management Sciences, magna cum laude.
Vice President, Operations
Mr. Walters co-founded Daré Bioscience Operations, Inc. in 2015 and has served as Vice President of Operations and Projects since the company’s inception. Following the company’s business combination with Cerulean Pharma Inc. on July 19, 2017, he has continued in this role with the renamed company, Daré Bioscience, Inc. Prior to Daré, he was President of Walters Consulting Partners where he advised the pharmaceutical and medical device industries on business development, development and regulatory approaches, and corporate and commercialization strategies. Mark served as Senior Vice President, Technical Operations and Vice President, Business and Commercial Development for Pacira Pharmaceuticals, and SkyePharma prior to its acquisition by Pacira. He spent twelve years at Alliance Pharmaceutical Corp. in various roles directing product development, project management, marketing and sales. Mr. Walters is an inventor on six issued patents in the fields of imaging and ventilator support. He received his degree in biology from Hamilton College.